Iain Mcinnes

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA.

BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY.

British Broadcasting Corp. provides broadcasting services. It offers news, sport, weather reports, DVD shopping, videos, travel, capital, culture, music, nature, food and local news. The company was founded by John Charles Walsham Reith in 1922 and is headquartered in White City, the United Kingdom.

Scottish Equity Partners LLP (Scottish Equity Partners) is a private equity firm founded in 1991 by Gary de Vinchelez Le Sueur and Andrew S. Paterson. The firm is headquartered in London, the United Kingdom.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

National Health Service provides health care services. It offers hospital services, family doctors, dentists, opticians and pharmacists and local authority health services, community nursing and health care services. The company was founded by Aneurin Bevan on July 5, 1948 and is headquartered in London, the United Kingdom.

Part of AstraZeneca PLC, AstraZéneca Farmacéutica Spain SA is a Spanish pharmaceutical company that produces pharmaceutical products. The company is based in Madrid, Spain.

Panoramic Growth Equity (Fund Management) LLP (Panoramic Growth Equity) is a private equity firm founded in 2009 by David Wilson, Stephen Campbell and Malcolm Kpedekpo. The firm is headquartered in London, United Kingdom.

Lowe Rental Ltd. engages in the provision of short term refrigeration rental services to the food exhibitions, events, retailers and food producers with rental solutions and equipment sales. The company was founded by Rodney Lowry in 1977 and is headquartered in Lisburn, the United Kingdom.

National Institute for Health & Care Excellence provides national guidance and advice to improve health and social care. The firm's programs include financial planning, advice, shared learning, standards and indicators and topic selections. The company was founded in 1999 and is headquartered in London, the United Kingdom.

Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.

Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.

Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.

Frost Investments Ltd. is a British company that engages in the rental and distribution of refrigeration and catering equipment. The private company is based in Lisburn, UK and has subsidiaries in the UK. It was founded in 2014.

Lowe Refrigeration Solutions Ltd. provides professional engineering services. The company is headquartered in Lisburn, the United Kingdom.

Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA.

SQI Investments Ltd. provides other business support services.

Part of PW P27 Ltd., P27 Topco Ltd. is a business services firm founded in 2018 that helps organizations in financial services, tech, and other sectors plan and deliver sustainable change. The company is based in London, UK and focuses on financial services, technology, automotive, and FMCG. The British company offers a strategic change diagnostic tool to assess change team gaps and ensure businesses are change-ready. Additionally, P27 Topco provides expert consultations and structured business services to complement clients' capabilities. P27 Topco also operates the Green Business Marketplace (GBM), which lists projects and businesses that provide solutions to transition to a greener economy.

Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation.

Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021.

Sonata Therapeutics, Inc. is a pioneering private company based in Cambridge, MA that designs single therapeutics to reprogram diseased cells and create curative microenvironments. The company's machine learning-based platform identifies novel insights, targets, and therapeutics across a wide range of disease areas, with a growing pipeline of small molecule drugs and genetic therapeutics. In oncology, Sonata's transformative therapies reprogram cancer cells to release curative signals that reverse immune cell suppression and blockade, empowering the immune system to holistically eradicate tumors and drive cure. Sonata Therapeutics is creating a new class of network medicines™ designed to modulate all the key cell types in a disease microenvironment required to drive disease resolution. The company is also exploring additional therapeutic areas such as fibrosis and tissue regeneration where multicellular networks play a key role. The company has subsidiaries in the United States. The company was founded in 2022 by flagship pioneering, and the CEO is Volker Herrmann.

Chemify Ltd. is a company based in Glasgow, UK that leverages chemistry experience, hardware robotics, and artificial intelligence to provide an end-to-end workflow for drug discovery, molecule synthesis, and materials discovery. By digitizing chemistry, Chemify is reimagining chemical research, discovery, and manufacturing to benefit humanity by accelerating advances across chemistry, with a focus on medicine and functional materials. The British company was founded in 2019 by CEO Lee Cronin, who conceptualized advancements from his digital chemistry laboratory at the University of Glasgow.